Compare Spotify Technology (SPOT) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Spotify Technology vs Tempus AI — how do they compare? Spotify Technology trades at $528 (market cap $108.22B), while Tempus AI trades at $70.15 (market cap $12.58B). The key difference: Spotify Technology is far larger — about 8.6× Tempus AI's market cap, and Tempus AI is more actively traded (7,444,569 versus 1,655,796). Which is the better fit depends on your goals — on Pluang, investors hold Spotify Technology for 111 Days and Tempus AI for 22 Days on average.
| SPOT | TEM | |
|---|---|---|
Market Cap | $108.22B | $12.58B |
Volume | 1,655,796 | 7,444,569 |
Sector | Media | Broad Market / Factor |
52-Week High | $692.04 | $99.28 |
52-Week Low | $412.75 | $41.55 |
Typical Hold Time | 111 Days | 22 Days |
Enterprise Value | $98.23B | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Spotify (SPOT) trades at $512.92, up 5.08% with strong bullish momentum. The stock shows robust fundamentals with revenue growth from $17.19B in 2025 to projected $18.1B in 2026, while net income margin expanded to 18.43%. Technical indicators signal bullish sentiment with price above key support at $497. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results pending.
Outlook remains positive with analyst consensus target of $608.18 representing 18.6% upside. Key opportunities include gross margin expansion and new monetization tools, while risks involve competitive pressures and market volatility. Wall Street maintains strong buy sentiment with 62% of analysts recommending purchase.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
